HBV vaccines and methods treating HBV
US11730808B2 · kind B2 · utility
1Cited by
41References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2022 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Oct 3, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are HBV immunogenic polypeptides, polynucleotides encoding such polypeptides, vectors expressing such immunogenic polypeptides for use in eliciting an immune response against HBV; pharmaceutical and immunogenic compositions and kits comprising such polypeptides, polynucleotides or vectors, and methods of use in treating and/or preventing HBV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.